Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Pathologica|March 14, 2024
Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literatureAlessandro Marando, Moreno Zagni, Mariachiara Negrelli, et al.JTO Clinical and Research Reports|December 4, 2023
Repotrectinib Overcomes F2004V Resistance Mutation in ROS1-Rearranged NSCLC: A Case ReportElio Gregory Pizzutilo, Alberto Giuseppe Agostara, Laura Roazzi, et al.Expert Review of Respiratory Medicine|October 11, 2023
What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and reviewAlberto Giuseppe Agostara, Laura Roazzi, Federica Villa, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patientsCesare Gridelli, Silvia Novello, Nicoletta Zilembo, et al.Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancerFederico Cappuzzo, Alessandro Morabito, Nicola Normanno, et al.Critical Reviews in Oncology/Hematology|February 2, 2024
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approachGiovanni Luca Ceresoli, Giulio Rossi, Francesco Agustoni, et al.Clinical Lung Cancer|December 20, 2018
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR MutationsAntonio Passaro, Arsela Prelaj, Laura Bonanno, et al.Clinical Lung Cancer|June 28, 2020
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective StudyAndrea Luciani, Antonio Marra, Luca Toschi, et al.British Journal of Cancer|December 4, 2015
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancerAlessio Amatu, Alessio Somaschini, Giulio Cerea, et al.Journal of Clinical Pathology|May 27, 2018
TRKA expression and NTRK1 gene copy number across solid tumoursGianluca Mauri, Emanuele Valtorta, Giulio Cerea, et al.Pageof 3